Literature DB >> 8129037

Localization of the 92 kd gelatinase mRNA in squamous cell and adenocarcinomas of the lung using in situ hybridization.

R Canete-Soler1, L Litzky, I Lubensky, R J Muschel.   

Abstract

We have used in situ hybridization for RNA to localize cells containing mRNA for the 92 kd gelatinase in carcinomas of the lung. We used archival material to analyze sections from 12 cases of squamous cell carcinomas of the lung including six stage I and three stage II and from three cases of adenocarcinoma of the lung. Presence of mRNA in the tissue was verified by in situ hybridization for gamma actin. The 92 kd gelatinase mRNA was found in all 12 squamous cell carcinomas tumors and was highly expressed in the tumor cells themselves. In addition, it was found in host stromal cells surrounding the tumor, but not in normal lung fibroblasts. In contrast it was not found in the adenocarcinomas of the lung or in the stroma surrounding these tumors. The mRNA for the 92 kd gelatinase was present in normal pulmonary tissue, bronchial epithelium, basal cell hyperplasia of bronchial epithelium, alveolar macrophages, and focally in bronchial mucous glands. It was not present in normal alveoli, vascular cells, cartilage, or most lymphocytes. We corroborated the presence of the mRNA for the 92 kd gelatinase by ribonuclease protection assay. The levels of mRNA for the 92 kd gelatinase in two specimens of squamous cell carcinoma were 6- to 10-fold greater than in the nonneoplastic tissue and two adenocarcinoma specimens.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8129037      PMCID: PMC1887096     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  36 in total

1.  Rabbit bone collagenase inhibitor blocks the activity of other neutral metalloproteinases.

Authors:  A Sellers; G Murphy; M C Meikle; J J Reynolds
Journal:  Biochem Biophys Res Commun       Date:  1979-03-30       Impact factor: 3.575

2.  A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas.

Authors:  P Basset; J P Bellocq; C Wolf; I Stoll; P Hutin; J M Limacher; O L Podhajcer; M P Chenard; M C Rio; P Chambon
Journal:  Nature       Date:  1990 Dec 20-27       Impact factor: 49.962

3.  Neutral metalloproteinases produced by human mononuclear phagocytes. Enzyme profile, regulation, and expression during cellular development.

Authors:  H G Welgus; E J Campbell; J D Cury; A Z Eisen; R M Senior; S M Wilhelm; G I Goldberg
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

4.  Immunohistochemical distribution of type IV collagenase in normal, benign, and malignant breast tissue.

Authors:  C Monteagudo; M J Merino; J San-Juan; L A Liotta; W G Stetler-Stevenson
Journal:  Am J Pathol       Date:  1990-03       Impact factor: 4.307

5.  Dissociation of tissue inhibitor of metalloproteinases (TIMP) from enzyme complexes yields fully active inhibitor.

Authors:  G Murphy; P Koklitis; A F Carne
Journal:  Biochem J       Date:  1989-08-01       Impact factor: 3.857

6.  Mr 92,000 gelatinase release correlates with the metastatic phenotype in transformed rat embryo cells.

Authors:  E J Bernhard; R J Muschel; E N Hughes
Journal:  Cancer Res       Date:  1990-07-01       Impact factor: 12.701

7.  Induction and stimulation of 92-kDa gelatinase/type IV collagenase production in osteosarcoma and fibrosarcoma cell lines by tumor necrosis factor alpha.

Authors:  Y Okada; H Tsuchiya; H Shimizu; K Tomita; I Nakanishi; H Sato; M Seiki; K Yamashita; T Hayakawa
Journal:  Biochem Biophys Res Commun       Date:  1990-09-14       Impact factor: 3.575

8.  SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages.

Authors:  S M Wilhelm; I E Collier; B L Marmer; A Z Eisen; G A Grant; G I Goldberg
Journal:  J Biol Chem       Date:  1989-10-15       Impact factor: 5.157

9.  Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteases designated TIMP-2.

Authors:  G I Goldberg; B L Marmer; G A Grant; A Z Eisen; S Wilhelm; C S He
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

10.  The mRNA coding for the secreted protease transin is expressed more abundantly in malignant than in benign tumors.

Authors:  L M Matrisian; G T Bowden; P Krieg; G Fürstenberger; J P Briand; P Leroy; R Breathnach
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

View more
  18 in total

Review 1.  The plasmin cascade and matrix metalloproteinases in non-small cell lung cancer.

Authors:  G Cox; W P Steward; K J O'Byrne
Journal:  Thorax       Date:  1999-02       Impact factor: 9.139

2.  Expression of urokinase-type plasminogen activator, stromelysin 1, stromelysin 3, and matrilysin genes in lung carcinomas.

Authors:  I Bolon; M Devouassoux; C Robert; D Moro; C Brambilla; E Brambilla
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

3.  Inhibition of gelatinase activity in human airway epithelial cells and fibroblasts by dexamethasone and beclomethasone.

Authors:  J E Carver; W A Galloway; C Robinson
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

Review 4.  The pathophysiology and management of spine metastasis from lung cancer.

Authors:  J S Greenberger
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

5.  Immunohistochemical study of metalloproteinases and their tissue inhibitors in the lungs of patients with diffuse alveolar damage and idiopathic pulmonary fibrosis.

Authors:  T Hayashi; W G Stetler-Stevenson; M V Fleming; N Fishback; M N Koss; L A Liotta; V J Ferrans; W D Travis
Journal:  Am J Pathol       Date:  1996-10       Impact factor: 4.307

Review 6.  Matrix metalloproteinases. Novel targets for directed cancer therapy.

Authors:  A E Yu; R E Hewitt; E W Connor; W G Stetler-Stevenson
Journal:  Drugs Aging       Date:  1997-09       Impact factor: 3.923

7.  Matrix metalloproteinase 9 promoter activity is induced coincident with invasion during tumor progression.

Authors:  M E Kupferman; M E Fini; W J Muller; R Weber; Y Cheng; R J Muschel
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

8.  Metastatic and non-metastatic colorectal cancer (CRC) cells induce host metalloproteinase production in vivo.

Authors:  S Mc Donnell; V Chaudhry; J Mansilla-Soto; Z S Zeng; W P Shu; J G Guillem
Journal:  Clin Exp Metastasis       Date:  1999-06       Impact factor: 5.150

9.  Tumorigenic potential of extracellular matrix metalloproteinase inducer.

Authors:  S Zucker; M Hymowitz; E E Rollo; R Mann; C E Conner; J Cao; H D Foda; D C Tompkins; B P Toole
Journal:  Am J Pathol       Date:  2001-06       Impact factor: 4.307

Review 10.  Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis.

Authors:  J R MacDougall; L M Matrisian
Journal:  Cancer Metastasis Rev       Date:  1995-12       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.